An eye drop marketed as Clear Eyes Maximum Itchy Eye Relief (NDC: 67172-999-01 UPC 6 78112 65920 3) was recalled initially by the FDA on July 29, 2026, because of “lack of assurance of sterility.” ...
Carl Zeiss Meditec AG has secured FDA 510(k) clearance for ZEISS CLINIC 360, an all-in-one cloud and browser-based software ...
Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS ...
Amy Zhang, MD, associate clinical professor in the glaucoma service at the Kellogg Eye Center, University of Michigan, spoke with Ophthalmology Times about the ergonomic habits that protect surgeons' ...
Keratoconus is often filed away as a young-adult diagnosis, but for pediatric and adolescent patients the disease can behave ...
The study sought to determine if the Real Architecture for 3D Tissues–Ocular Surface (RAFT-OS) transplant that included ...
Phase 3 DURAVYU insert misses key vision endpoint in wet AMD but cuts injections; pivotal LUCIA readout may decide its future ...
Byron Lam, MD, and Benjamin Bakall, MD, PhD, discuss what an FDA approval of tinlarebant could mean for the Stargardt disease ...
Since I started offering robotic laser cataract surgery, I have always been straightforward with patients, but it surprised me how much they lit up when they heard me say during a surgical ...
In this episode of The Retina TL;DR with Dr. Weng, powered by Modern Retina, host Christina Y. Weng, MD, MBA, FASRS, ...
COMO (NCT07449936) and CAPRI (NCT07449923), the two global Phase 3 trials of EYP-1901 vorolanib intravitreal insert (DURAVYU) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results